Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Bruserud

Showing results (41-50 of 108) with videos related to

Pageof 11
Sort By:
European Journal of Haematology|March 25, 1999
In vitro effects of insulin-like growth factor-1 (IGF-1) on proliferation and constitutive cytokine secretion by acute myelogenous leukemia blastsS Frostad, O Bruserud
Stem Cells (Dayton, Ohio)|June 7, 2000
New strategies for the treatment of acute myelogenous leukemia: differentiation induction--present use and future possibilitiesO Bruserud, B T Gjertsen
Scandinavian Journal of Clinical and Laboratory Investigation|May 11, 2002
Circadian variations do not have a major impact on serum levels of soluble (S) L-selectin (CD63L), S-intercellular adhesion molecule 1 (sICAM-1/CD54) and thrombopoietin in healthy individualsK A Mosevold, O Bruserud
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 20, 1983
[Hyperosmolar nonketotic diabetic coma]O Bruserud, T P Leren
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 30, 1986
[Cyclosporin A. Inhibitory effect on T lymphocytes]P F Jørgensen, O Bruserud
Cancer Chemotherapy and Pharmacology|January 1, 1995
In vitro effect of r-verapamil on acute myelogenous leukemia blast cells: studies of cytokine secretion and cytokine-dependent blast proliferationO Bruserud, I Nesthus, G Pawelec
Diabetologia|July 1, 1985
HLA-DR3 and -DR4 control T-lymphocyte responses to mumps and Coxsackie B4 virus: studies on patients with type 1 (insulin-dependent) diabetes and healthy subjectsO Bruserud, J Jervell, E Thorsby
Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section C, Immunology|August 1, 1987
The mumps-specific T cell response in healthy individuals and insulin-dependent diabetics: preferential restriction by DR4-associated elementsO Bruserud, G Paulsen, E Thorsby
European Journal of Haematology|August 8, 2001
Platelet-derived growth factor (PDGF) in human acute myelogenous leukemia: PDGF receptor expression, endogenous PDGF release and responsiveness to exogenous PDGF isoforms by in vitro cultured acute myelogenous leukemia blastsB Foss, E Ulvestad, O Bruserud
Current Cancer Drug Targets|September 17, 2009
Heat shock protein 90 - a potential target in the treatment of human acute myelogenous leukemiaH Reikvam, E Ersvaer, O Bruserud
Pageof 11

Showing results (41-50 of 108) with videos related to

Sort By:
Pageof 11
European Journal of Haematology|March 25, 1999
In vitro effects of insulin-like growth factor-1 (IGF-1) on proliferation and constitutive cytokine secretion by acute myelogenous leukemia blastsS Frostad, O Bruserud
Stem Cells (Dayton, Ohio)|June 7, 2000
New strategies for the treatment of acute myelogenous leukemia: differentiation induction--present use and future possibilitiesO Bruserud, B T Gjertsen
Scandinavian Journal of Clinical and Laboratory Investigation|May 11, 2002
Circadian variations do not have a major impact on serum levels of soluble (S) L-selectin (CD63L), S-intercellular adhesion molecule 1 (sICAM-1/CD54) and thrombopoietin in healthy individualsK A Mosevold, O Bruserud
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 20, 1983
[Hyperosmolar nonketotic diabetic coma]O Bruserud, T P Leren
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 30, 1986
[Cyclosporin A. Inhibitory effect on T lymphocytes]P F Jørgensen, O Bruserud
Cancer Chemotherapy and Pharmacology|January 1, 1995
In vitro effect of r-verapamil on acute myelogenous leukemia blast cells: studies of cytokine secretion and cytokine-dependent blast proliferationO Bruserud, I Nesthus, G Pawelec
Diabetologia|July 1, 1985
HLA-DR3 and -DR4 control T-lymphocyte responses to mumps and Coxsackie B4 virus: studies on patients with type 1 (insulin-dependent) diabetes and healthy subjectsO Bruserud, J Jervell, E Thorsby
Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section C, Immunology|August 1, 1987
The mumps-specific T cell response in healthy individuals and insulin-dependent diabetics: preferential restriction by DR4-associated elementsO Bruserud, G Paulsen, E Thorsby
European Journal of Haematology|August 8, 2001
Platelet-derived growth factor (PDGF) in human acute myelogenous leukemia: PDGF receptor expression, endogenous PDGF release and responsiveness to exogenous PDGF isoforms by in vitro cultured acute myelogenous leukemia blastsB Foss, E Ulvestad, O Bruserud
Current Cancer Drug Targets|September 17, 2009
Heat shock protein 90 - a potential target in the treatment of human acute myelogenous leukemiaH Reikvam, E Ersvaer, O Bruserud
Pageof 11